In March 2025, the company introduced new ideas for a direct-to-client offering of its Wegovy weight loss drug. The company set up a completely new pharmacy, called NovoCare, which would cost clients $499 per 30 days for usage of the drug, fewer than 50 percent the expense of the drug as a result of other pharmaceutical distribution networks.[fifty